Munich offers success through collaboration

July 15, 2015 Erin Righetti

^B6300D0A8A86CC60EDA2F3C35DB8DC5BB471BE96DF9162CEFB^pimgpsh_fullsize_distrMunich, Germany, is home to a broad spectrum of high-capacity industries including life sciences; information and communication technology; automotive; aerospace; financial services; cross-industry technologies; skilled crafts; media/creative industries and corporate services.

A growing city, Munich has 1.46 million inhabitants (2013) and expects to grow to 1.65 million inhabitants by 2030. Together with its periphery, this number increases to 2.73 million current inhabitants with an expectation to grow to 3 million inhabitants by 2030. A well-known commercial hub, it is the seat of two excellent universities, with orchestras that are in the top tier of the world. Yet, for all that, Munich is an easy-going city, a virtue it has retained while evolving from being the small capital of the Bavarian kingdom to a friendly and cosmopolitan metropolis.

Importantly, Munich is a leading business location in Europe with a gross domestic product (2011) of EUR 79.8 billion and the base for 94,800 companies (2013). Munich’s economic structure is diverse: The famous “Munich Mix” comprises global players and SMEs, high-tech production and craftsmen, innovation and knowledge hubs, a huge startup community and diverse services. The life sciences are thriving in Munich: there are over 270 life science companies in the Munich Biotech Cluster, known as BioM Biotech Cluster Development GmbH (BioM), making it a leading biotech location and one of Europe’s hot spots for research and innovation.

BIO-Europe® is Europe’s largest partnering event of the year. Dealmakers from all parts of the biotechnology value chain are ready to accelerate their businesses by quickly identifying, engaging

and entering into strategic relationships with innovative companies. Spark new collaborations with global partners by attending BIO-Europe this November 2–4 in Munich.
Find more reasons to attend BIO-Europe, read Spotlight on Munich.


Erin Righetti is Editor of partnering360® Blog. Any views expressed are hers and not those of Informa.


Previous Article
partnering360® announces 30,000th member contest winner
partnering360® announces 30,000th member contest winner

partnering360®, the open online community of life science dealmakers dedicated to enhancing partnering expe...

Next Article
ASCO meeting highlights cancer breakthroughs
ASCO meeting highlights cancer breakthroughs

Guest post by Manasi Vaidya, Healthcare Reporter at BioPharm Insight This year’s annual American Society of...